| 產品名稱 |
Influenza B virus |
| 商品貨號 |
B203961 |
| Classification |
Orthomyxoviridae, Influenzavirus B |
| Agent |
Influenza B virus |
| Strain |
B/Russia/69 |
| Applications |
Influenza Research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Influenza patient |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host |
Tumorigenicity, hemagglutination activity ?Hemagglutination of Chicken RBC?s |
| Recommended Host |
chicken embryo Recommended Host:? SPF CE (10 to 11 day old, intra allantoic) |
| Growth Conditions |
Temperature: 37.0°C Duration: 1-4 days |
| Name of Depositor |
R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Influenza patient |
| References |
Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976
Smorodintsev A. The efficacy of live influenza vaccines. Bull. World Health Organ. 41: 585-588, 1969. PubMed: 5309480
|
